FDA advisers meet to decide next COVID-19 booster shot
Jun 14, 2023
In a briefing paper, scientists say that a redesigned boosters should target at least one variant of the XBB strains.
Rates of COVID-19, severe illness lower with BNT162b2 booster dose
Dec 09, 2021
A second study shows a reduction in the rate of death due to COVID-19 with a booster dose of BNT162b2 (Pfizer–BioNTech).
Noticeably absent from COVID-19 bill: support for seniors and caregivers, association leaders say
By
Joe Jancsurak
Mar 04, 2021
The COVID-19 relief bill passed by the House of Representatives and now before the Senate is seriously lacking support for seniors and care providers, association leaders say.
Breakthrough COVID-19 infection risk higher with immune dysfunction
Dec 28, 2021
A breakthrough infection after full vaccination was more likely among older people and women.
Molnupiravir cuts risk for severe COVID-19 illness in adults
Dec 20, 2021
The risk for hospitalization or death was lower in at-risk adults with mild-to-moderate COVID-19 receiving oral therapy with molnupiravir versus placebo.
Online breathing program can up mental health-related quality of life in long COVID
May 03, 2022
Significant improvement was seen in the mental health composite score but not in physical composite score of health-related quality of life.
Thrombosis, thrombocytopenia syndrome up after Ad26.COV2.S
Jan 28, 2022
Rates of 3.83 per million vaccine doses for Ad26.COV2.S (Johnson & Johnson) have been reported, versus 0.00855 per million for mRNA-based vaccines such as Pfizer-BioNTech and Moderna.
REGEN-COV reduces risk for COVID-19 hospitalization, death
Oct 01, 2021
Among outpatients with COVID-19 at high risk, the risk for hospitalization and death was reduced with the monoclonal antibody combo versus placebo.
Overestimation of oxygen saturation leads to delayed COVID-19 treatment
Aug 31, 2023
Patients with unrecognized need for COVID-19 therapy appear to have higher odds of readmission, regardless of race.
Mergers and acquisitions receive more scrutiny from buyers, experts say
By
Diane Eastabrook
Sep 02, 2021
It may be a seller’s market in the home care and hospice industry, but buyers are scrutinizing potential deals more closely.